| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1427.010 |
| P698 | PubMed publication ID | 19076432 |
| P2093 | author name string | Domenico Praticò | |
| P2860 | cites work | Evidence of increased oxidative damage in subjects with mild cognitive impairment. | Q34410726 |
| In vivo measurement of the redox state | Q34524247 | ||
| Oxidative damage is the earliest event in Alzheimer disease | Q43696731 | ||
| Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey | Q46849688 | ||
| Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease | Q53201201 | ||
| Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. | Q53895932 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxidative stress | Q898814 |
| Alzheimer's disease | Q11081 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 70-78 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows | |
| P478 | volume | 1147 |
| Q35417932 | ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy |
| Q37043396 | ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. |
| Q33683437 | Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes |
| Q35737647 | Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics |
| Q35867093 | Age-related neurodegeneration and memory loss in down syndrome |
| Q36499354 | Alterations of the volatile metabolome in mouse models of Alzheimer's disease |
| Q36927531 | Altered APP Carboxyl-Terminal Processing Under Ferrous Iron Treatment in PC12 Cells |
| Q38532705 | Alzheimer's Disease, Drosophila melanogaster and Polyphenols. |
| Q42921152 | An okadaic acid-induced model of tauopathy and cognitive deficiency. |
| Q37056966 | Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients |
| Q57766494 | Antioxidant Therapy and its Effectiveness in Oxidative Stress-Mediated Disorders |
| Q34631169 | Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. |
| Q35795151 | Antioxidants in the canine model of human aging |
| Q54918153 | Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer's disease. |
| Q57215020 | Association of Nutrient Intakes with Cognitive Function in Koreans Aged 50 years and Older |
| Q37420497 | Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways. |
| Q28259585 | Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease |
| Q33890252 | Bushen‑Yizhi formula ameliorates cognition deficits and attenuates oxidative stress‑related neuronal apoptosis in scopolamine‑induced senescence in mice |
| Q36252726 | Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection |
| Q57075993 | Chlorpyrifos Leads to Oxidative Stress-Induced Death of Hippocampal Cells in Vitro |
| Q38024119 | Cholinesterase inhibitors: a patent review (2007 - 2011). |
| Q37412437 | Chronic ramelteon treatment in a mouse model of Alzheimer's disease. |
| Q51849600 | Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. |
| Q92259337 | Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly |
| Q37947984 | Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. |
| Q46309586 | Copper and Alzheimer's Disease |
| Q37622792 | Copper in the brain and Alzheimer's disease |
| Q35738539 | Curcumin protects against intracellular amyloid toxicity in rat primary neurons. |
| Q33531807 | Cytotoxic aggregation and amyloid formation by the myostatin precursor protein |
| Q48450927 | Dementia in life writing: our health care system in the words of the sufferer |
| Q53458869 | Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease. |
| Q38815690 | Development of a neuroprotective potential algorithm for medicinal plants. |
| Q37973295 | Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis |
| Q50635685 | Effect of licofelone--a dual COX/5-LOX inhibitor in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats. |
| Q58691858 | Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives |
| Q37947939 | Elevation of glutathione as a therapeutic strategy in Alzheimer disease |
| Q54978852 | Ethyl Acetate Fraction from Persimmon (Diospyros kaki) Ameliorates Cerebral Neuronal Loss and Cognitive Deficit via the JNK/Akt Pathway in TMT-Induced Mice. |
| Q33467388 | Fine mapping of gene regions regulating neurodegeneration |
| Q39412092 | Flavonoid baicalein modulates H2O2-induced mitogen-activated protein kinases activation and cell death in SK-N-MC cells. |
| Q50502116 | Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia. |
| Q93090922 | Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity |
| Q43605489 | HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency |
| Q37808096 | Herba Epimedii: Anti-Oxidative Properties and Its Medical Implications |
| Q34306241 | Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease |
| Q38718867 | In-vitro and in-vivo evaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system. |
| Q39766604 | Increased iron and oxidative stress are separately related to cognitive decline in elderly |
| Q35606240 | Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo |
| Q64238656 | Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability |
| Q38252270 | Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity. |
| Q38619407 | Interpretation of mushroom as a common therapeutic agent for Alzheimer's disease and cardiovascular diseases |
| Q35996874 | Mechanism of oxidative stress in neurodegeneration |
| Q37855656 | Mechanisms of neural and behavioral dysfunction in Alzheimer's disease |
| Q36698716 | Methionine sulfoxide reductase A affects β-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease |
| Q48314660 | Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease. |
| Q33603868 | Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans |
| Q27009475 | Mitochondrial dysfunction: different routes to Alzheimer's disease therapy |
| Q23923177 | Mitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactions |
| Q36026546 | Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. |
| Q33951174 | Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance |
| Q26744105 | Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease |
| Q42262002 | NADPH Oxidase Mediates β-Amyloid Peptide-Induced Neuronal Death in Mouse Cortical Cultures |
| Q33900736 | NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology |
| Q97684616 | Neural stem cell conditioned medium alleviates Aβ25-35 damage to SH-SY5Y cells through the PCMT1/MST1 pathway |
| Q34624910 | Neuronal calcium homeostasis and dysregulation |
| Q37691309 | Nutritional issues in treating phenylketonuria |
| Q28396288 | Organic silicon protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide effects |
| Q37133480 | Oxidative modification of lipoic acid by HNE in Alzheimer disease brain |
| Q37737299 | Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents |
| Q47658587 | Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease |
| Q36474703 | Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy |
| Q45937554 | Oxidative stress triggers neuronal caspase-independent death: endonuclease G involvement in programmed cell death-type III. |
| Q42690849 | Ozone as u-shaped dose responses molecules (hormetins). |
| Q37204006 | Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease. |
| Q38286222 | Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets. |
| Q38037157 | Plasma biomarkers for Alzheimer's disease: much needed but tough to find |
| Q30814231 | Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors |
| Q35101698 | Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration |
| Q47657359 | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
| Q37424178 | Protective Effects of Selol Against Sodium Nitroprusside-Induced Cell Death and Oxidative Stress in PC12 Cells |
| Q36622182 | Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes |
| Q41442163 | Reactive oxidative species enhance amyloid toxicity in APP/PS1 mouse neurons |
| Q50981798 | Reactive oxygen species are not involved in the onset of age-related memory impairment in Drosophila. |
| Q37262897 | SOD2 in mitochondrial dysfunction and neurodegeneration |
| Q36872331 | Selenium in the Therapy of Neurological Diseases. Where is it Going? |
| Q53362854 | Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer's disease. |
| Q91826157 | Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease |
| Q47862033 | Supplementation with Curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer's disease: A systematic review. |
| Q37553254 | Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment |
| Q37883102 | Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway. |
| Q44272311 | Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats. |
| Q33630562 | The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease? |
| Q58723369 | The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases |
| Q37793366 | The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration |
| Q58805053 | The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer's Diseased Mice Hearts |
| Q26771758 | The Role of Oxidative Stress in Neurodegenerative Diseases |
| Q37575502 | The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review. |
| Q37285146 | The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology |
| Q22242668 | The endocannabinoid system in normal and pathological brain ageing |
| Q35237112 | The role of astroglia in neuroprotection |
| Q48190046 | The synthesis and evaluation of novel hydroxyl substituted chalcone analogs with in vitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical-injury Alzheimer's model. |
| Q38198104 | Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism |
| Q35976705 | Total Lignans of Schisandra chinensis Ameliorates Aβ1-42-Induced Neurodegeneration with Cognitive Impairment in Mice and Primary Mouse Neuronal Cells |
| Q37680121 | Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction |
| Q37960498 | Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications |
| Q35601542 | WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture. |
| Q93081297 | β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer's Disease |
Search more.